Selektope Overview

  • Founded
  • 2000
Founded
  • Status
  • Public
  • Employees
  • 7
Employees
  • Stock Symbol
  • ITECH
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $5.92
  • (As of Friday Closing)

Selektope General Information

Description

I-Tech AB is a biotechnology company. The company owns all IP and regulatory rights to the antifouling agent Selektope. Its business is to commercialize patented active substance to reduce marine fouling on hulls, gears and other submerged structures. The company also controls the efficient source of medetomidine production.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Industrial Chemicals
Other Industries
Other Commercial Products
Other Chemicals and Gases
Stock Exchange
STO
Primary Office
  • Pepparedsleden 1
  • 431 83 Mölndal
  • Sweden
+46 031-788 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Selektope Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.92 $6.10 $5.83 - $11.38 $70.6M 11.9M 13.9K -$0.07

Selektope Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 83,891 114,207 80,746 83,471
Revenue 5,874 5,729 4,818 3,327
EBITDA 4 242 153 (684)
Net Income (685) (521) 891 (1,579)
Total Assets 14,165 14,650 14,046 13,742
Total Debt 0 1,051 1,220 1,488
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Selektope Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Selektope‘s full profile, request access.

Request a free trial

Selektope Executive Team (5)

Name Title Board Seat Contact Info
Philip Chaabane Chief Executive Officer
Magnus Henell Chief Financial Officer
Oliver Weigenand Ph.D Chief Operating Officer
Catherine Austin Director, Marketing & Communications
You’re viewing 4 of 5 executive team members. Get the full list »

Selektope Board Members (9)

Name Representing Role Since
Bertil Arvidsson Self Board Member 000 0000
Goran Wessman Vicore Pharma Holding Board Member 000 0000
Håkan Krook Almi Invest Board Member 000 0000
Leif Darner Self Board Member 000 0000
Mats Enegren Almi Invest Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Selektope Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Selektope Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Selektope‘s full profile, request access.

Request a free trial

Selektope Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 (000000000 30-Sep-2018 000000000 00000 00 Buildings and Property 000000 00000000
To view Selektope’s complete investments history, request access »